Overview

Myelodysplastic syndromes (MDS) are a group of rare blood disorders characterised by dysfunctional bone marrow, leading to inadequate production of healthy blood cells. This results in low blood counts and an increased risk of developing leukaemia. MDS often affects older individuals and can manifest as anaemia, bleeding, or susceptibility to infections.

Myelodysplastic syndromes primarily affect older adults, although they can occur at any age. The underlying causes of MDS remain unknown, involving genetic mutations, exposure to certain environmental toxins, and prior treatments such as chemotherapy or radiation therapy. MDS presents symptoms ranging from fatigue, pale skin, and easy bruising to more severe complications such as recurrent infections and bleeding. The impacts of MDS can be wide-ranging and profoundly affect a patient's health and quality of life. This article provides detailed information about its causes, symptoms, and treatment options available to patients and their healthcare providers.

Causes of Myelodysplastic Syndromes

The causes of MDS are only sometimes clear-cut, and a combination of genetic, environmental, and lifestyle factors can influence them. Here are some known and potential causes of myelodysplastic syndromes:

- Environmental Allergens. Prolonged exposure to certain environmental toxins and chemicals, such as benzene or certain chemotherapy drugs, as well as ionising radiation, may increase the risk of developing MDS.
- Genetic Mutations. Some individuals may inherit genetic mutations that cause them to MDS.
- The risk of developing MDS increases with age.
- Viral Infections. Certain viral infections, such as the human immunodeficiency virus (HIV) and the Epstein-Barr virus (EBV), have been associated with an increased risk of developing MDS.
- Cancer Treatments. Specific cancer treatments, such as chemotherapy and radiation therapy, can damage the bone marrow, potentially leading to the development of MDS as a secondary condition.

Symptoms of Myelodysplastic Syndrome

Individuals with MDS may experience a range of symptoms, which can vary in severity. Here are some common symptoms associated with myelodysplastic syndromes:

- Fatigue and a sense of weakness
- Rapid or irregular heartbeat
- Paleness, shortness of breath
- Experiencing frequent bruising or bleeding due to a decrease in the number of platelets
- Individuals more susceptible to infections
- Abdominal discomfort, fullness, or pain in the left upper abdomen
- Recurrent fevers

How is myelodysplastic syndrome diagnosed?

Diagnosing this syndrome involves a series of medical evaluations and tests.

- Medical History & Physical Examination. It typically begins with a comprehensive medical history and physical examination, during which the healthcare provider may inquire about symptoms such as fatigue, weakness, easy bruising, or recurrent infections.
- Initial Assessments. Following this initial assessment, blood tests play a crucial role in the diagnostic process. A complete blood count (CBC) is performed to evaluate the levels of red blood cells, white blood cells, and platelets.
- Biopsy. With the help of bone marrow aspiration and biopsy, healthcare providers directly examine the bone marrow, looking for abnormalities in cell morphology and distribution.
- Imaging Tests. Imaging tests such as CT scans or MRIs are also performed to assess for any abnormalities in the organs or lymph nodes.

Treatment Options For Myelodysplastic Syndromes

Common treatment options include

- Chemotherapy. Chemotherapy drugs may suppress abnormal cell growth and improve blood cell production. This approach is particularly effective in some subtypes of MDS.
- Stem cell transplantation. For eligible patients, a stem cell transplant (also known as a bone marrow transplant) may offer a potential cure. It involves replacing the diseased bone marrow with healthy stem cells from a donor.
- Supportive Care. Supportive care measures, such as blood transfusions, growth factors, and antibiotics, are often used to manage symptoms and complications associated with MDS.
- Targeted Therapies. Certain medications target specific genetic mutations or pathways involved in the development of MDS. These therapies show promise for treating particular subtypes of the disorder.
- Clinical Trials. Sometimes, clinical trials that are specifically tailored to individual needs are performed.

When to Consult a Doctor

You can also get in touch with the expert Hematology doctors at Narayana Healthcare based in your city to get immediate attention and medical support during injuries, health disorders or any other health concern.

Conclusion

Myelodysplastic syndromes are a complex group of disorders that require a multidisciplinary approach to diagnosis and treatment. If you or a loved one suspects MDS, seeking a timely medical evaluation and discussing treatment options with a healthcare provider is crucial for the effective management of this condition.

References

- https://www.mayoclinic.org/diseases-conditions/myelodysplastic-syndrome/symptoms-causes/syc-20366977
- https://www.cancer.gov/types/myeloproliferative/patient/myelodysplastic-treatment-pdq